<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35867112</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex.</ArticleTitle><Pagination><StartPage>393</StartPage><EndPage>411</EndPage><MedlinePgn>393-411</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-022-02466-9</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of motor neurons in the motor cortex, brainstem, and spinal cord. Although ALS is considered a motor neuron disorder, neuroinflammation also plays an important role. Recent evidence in ALS disease models indicates activation of the inflammasome and subsequent initiation of pyroptosis, an inflammatory type of cell death. In this study, we determined the expression and distribution of the inflammasome and pyroptosis effector proteins in post-mortem brain and spinal cord from ALS patients (n&#x2009;=&#x2009;25) and controls (n&#x2009;=&#x2009;19), as well as in symptomatic and asymptomatic TDP-43<sup>A315T</sup> transgenic and wild-type mice. Furthermore, we evaluated its correlation with the presence of TDP-43 pathological proteins and neuronal loss. Expression of the NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome, pyroptosis effector protein cleaved Gasdermin D (GSDMD), and IL-18 was detected in microglia in human ALS motor cortex and spinal cord, indicative of canonical inflammasome-triggered pyroptosis activation. The number of cleaved GSDMD-positive precentral white matter microglia was increased compared to controls and correlated with a decreased neuronal density in human ALS motor cortex. Neither of this was observed in the spinal cord. Similar results were obtained in TDP-43<sup>A315T</sup> mice, where microglial pyroptosis activation was significantly increased in the motor cortex upon symptom onset, and correlated with neuronal loss. There was no significant correlation with the presence of TDP-43 pathological proteins both in human and mouse tissue. Our findings emphasize the importance of microglial NLRP3 inflammasome-mediated pyroptosis activation for neuronal degeneration in ALS and pave the way for new therapeutic strategies counteracting motor neuron degeneration in ALS by inhibiting microglial inflammasome/pyroptosis activation.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Van Schoor</LastName><ForeName>Evelien</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), O&amp;N IV Herestraat 49-bus 1032, 3000, Leuven, Belgium. evelien.vanschoor@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Department of Neurosciences, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium. evelien.vanschoor@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, VIB, Leuven, Belgium. evelien.vanschoor@kuleuven.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ospitalieri</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), O&amp;N IV Herestraat 49-bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moonen</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), O&amp;N IV Herestraat 49-bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, Department of Neurosciences, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tom&#xe9;</LastName><ForeName>Sandra O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), O&amp;N IV Herestraat 49-bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronisz</LastName><ForeName>Alicja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), O&amp;N IV Herestraat 49-bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ok</LastName><ForeName>Orkun</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), O&amp;N IV Herestraat 49-bus 1032, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Divisions of Neurodegeneration, Department of Neurology, Mannheim Center for Translational Neurosciences, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Department of Neurosciences, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Department of Neurosciences, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Dietmar Rudolf</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-1036-1075</Identifier><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven (University of Leuven), Leuven Brain Institute (LBI), O&amp;N IV Herestraat 49-bus 1032, 3000, Leuven, Belgium. dietmar.thal@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University Hospitals Leuven, Leuven, Belgium. dietmar.thal@kuleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069292" MajorTopicYN="N">Pyroptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="Y">White Matter</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Inflammasome</Keyword><Keyword MajorTopicYN="N">Pyroptosis</Keyword><Keyword MajorTopicYN="N">Transactive response DNA-binding protein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35867112</ArticleId><ArticleId IdType="doi">10.1007/s00401-022-02466-9</ArticleId><ArticleId IdType="pii">10.1007/s00401-022-02466-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Banerjee P, Elliott E, Rifai OM, O&#x2019;Shaughnessy J, McDade K, Abrahams S et al (2022) NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis. J Pathol 256:262&#x2013;268. https://doi.org/10.1002/path.5846</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5846</ArticleId><ArticleId IdType="pubmed">34883532</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellezza I, Grottelli S, Costanzi E, Scarpelli P, Pigna E, Morozzi G et al (2018) Peroxynitrite activates the NLRP3 inflammasome cascade in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Mol Neurobiol 55:2350&#x2013;2361. https://doi.org/10.1007/s12035-017-0502-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0502-x</ArticleId><ArticleId IdType="pubmed">28357805</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389&#x2013;404. https://doi.org/10.1007/s00401-006-0127-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0127-z</ArticleId><ArticleId IdType="pubmed">16906426</ArticleId><ArticleId IdType="pmc">3906709</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J et al (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119:497&#x2013;503. https://doi.org/10.1016/j.clinph.2007.09.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho M, Swash M (2009) Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 10:53&#x2013;57. https://doi.org/10.1080/17482960802521126</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802521126</ArticleId><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>Debray S, Race V, Crabb&#xe9; V, Herdewyn S, Matthijs G, Goris A et al (2013) Frequency of C9Orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study. Neurobiol Aging 34:2890.e7-2890.e12. https://doi.org/10.1016/j.neurobiolaging.2013.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.06.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Debye B, Schm&#xfc;lling L, Zhou L, Rune G, Beyer C, Johann S (2018) Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice. Brain Pathol 28:14&#x2013;27. https://doi.org/10.1111/bpa.12467</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12467</ArticleId><ArticleId IdType="pubmed">27880990</ArticleId></ArticleIdList></Reference><Reference><Citation>Denes A, Brough D (2012) Caspase-1: is IL-1 just the tip of the ICEberg? Cell Death Dis 3:e338. https://doi.org/10.1038/cddis.2012.86</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2012.86</ArticleId><ArticleId IdType="pubmed">22764097</ArticleId><ArticleId IdType="pmc">3406585</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V, Lee JD, Albornoz EA, Mcalary L, Jagaraj CJ, Robertson AAB et al (2019) The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia 68:407&#x2013;421. https://doi.org/10.1002/glia.23728</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23728</ArticleId><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>Espejo-Porras F, Piscitelli F, Verde R, Ramos JA, Di Marzo V, de Lago E et al (2015) Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders. J Neuroimmune Pharmacol 10:233&#x2013;244. https://doi.org/10.1007/s11481-015-9602-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-015-9602-4</ArticleId><ArticleId IdType="pubmed">25819934</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank D, Vince JE (2019) Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ 26:99&#x2013;114. https://doi.org/10.1038/s41418-018-0212-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0212-6</ArticleId><ArticleId IdType="pubmed">30341423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Wang L, Huntley ML, Perry G, Wang X (2018) Pathomechanisms of TDP-43 in neurodegeneration. J Neurochem 146:7&#x2013;20. https://doi.org/10.1111/jnc.14327</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006&#x2013;1014. https://doi.org/10.1212/WNL.0b013e31821103e6</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId><ArticleId IdType="pmc">3059138</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y, Han F (2020) Key mechanisms and potential targets of the NLRP3 inflammasome in neurodegenerative diseases. Front Integr Neurosci 14:37. https://doi.org/10.3389/fnint.2020.00037</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnint.2020.00037</ArticleId><ArticleId IdType="pubmed">32792920</ArticleId><ArticleId IdType="pmc">7393579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliandolo A, Giacoppo S, Bramanti P, Mazzon E (2018) NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model. Inflammation 41:93&#x2013;103. https://doi.org/10.1007/s10753-017-0667-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-017-0667-5</ArticleId><ArticleId IdType="pubmed">28936769</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Prim 3:17071. https://doi.org/10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T, Bogdanik LP, Tassinari VR, Kidd JD, Moreno AJ, Davis C et al (2014) C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res 1584:59&#x2013;72. https://doi.org/10.1016/j.brainres.2013.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.10.013</ArticleId><ArticleId IdType="pubmed">24141148</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Kummer MP, Stutz A, Delekate A, Saecker A, Griep A et al (2013) NRLP3 is activated in Alzheimer&#x2019;s disease and contributes to pathology in APP/PS1 mice. Nature 493:674&#x2013;678. https://doi.org/10.1038/nature11729.NLRP3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11729.NLRP3</ArticleId><ArticleId IdType="pubmed">23254930</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdewyn S, Cirillo C, Van Den Bosch L, Robberecht W, Vanden Berghe P, Van Damme P (2014) Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice. Mol Neurodegener 9:24. https://doi.org/10.1186/1750-1326-9-24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-24</ArticleId><ArticleId IdType="pubmed">24938805</ArticleId><ArticleId IdType="pmc">4088917</ArticleId></ArticleIdList></Reference><Reference><Citation>Italiani P, Carlesi C, Giungato P, Puxeddu I, Borroni B, Boss&#xf9; P et al (2014) Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis. J Neuroinflammation 11:94. https://doi.org/10.1186/1742-2094-11-94</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-94</ArticleId><ArticleId IdType="pubmed">24884937</ArticleId><ArticleId IdType="pmc">4039322</ArticleId></ArticleIdList></Reference><Reference><Citation>Johann S, Heitzer M, Kanagaratnam M, Goswami A, Rizo T, Weis J et al (2015) NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63:2260&#x2013;2273. https://doi.org/10.1002/glia.22891</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22891</ArticleId><ArticleId IdType="pubmed">26200799</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadhim H, Deltenre P, Martin JJ, S&#xe9;bire G (2016) In-situ expression of Interleukin-18 and associated mediators in the human brain of sALS patients: Hypothesis for a role for immune-inflammatory mechanisms. Med Hypotheses 86:14&#x2013;17. https://doi.org/10.1016/j.mehy.2015.11.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2015.11.022</ArticleId><ArticleId IdType="pubmed">26804591</ArticleId></ArticleIdList></Reference><Reference><Citation>Koper MJ, Van Schoor E, Ospitalieri S, Vandenberghe R, Vandenbulcke M, Von Arnim CAF et al (2019) Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer&#x2019;s disease. Acta Neuropathol 139:463&#x2013;484. https://doi.org/10.1007/s00401-019-02103-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02103-y</ArticleId><ArticleId IdType="pubmed">31802237</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal-lasarte M, Franco JM, Labrador-garrido A, Pozo D (2017) Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3 / IL-18 signaling in microglia. FASEB 7:2797&#x2013;2816. https://doi.org/10.1096/fj.201601163R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201601163R</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Hamanaka G, Lo EH, Arai K (2019) Heterogeneity of microglia and their differential roles in white matter pathology. CNS Neurosci Ther 25:1290&#x2013;1298. https://doi.org/10.1111/cns.13266</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13266</ArticleId><ArticleId IdType="pubmed">31733036</ArticleId><ArticleId IdType="pmc">6887901</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Hyeon SJ, Im H, Ryu H, Kim Y, Ryu H (2016) Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp Neurobiol 25:233. https://doi.org/10.5607/en.2016.25.5.233</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId><ArticleId IdType="pmc">5081469</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427&#x2013;434. https://doi.org/10.1002/ana.21147</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F, Molawi K, Zychlinsky A (2010) Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci 107:13046&#x2013;13050. https://doi.org/10.1073/pnas.1002396107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId><ArticleId IdType="pmc">2919927</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejias NH, Martinez CC, Stephens ME, De Rivero Vaccari JP (2018) Contribution of the inflammasome to inflammaging. J Inflamm 15:23. https://doi.org/10.1186/s12950-018-0198-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-018-0198-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirra SS, Heyman A, McKeel DW, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer&#x2019;s Disease (CERAD): II. Standardization of the neuropathologic assessment of Alzheimer&#x2019;s disease. Neurology 41:479&#x2013;486</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.41.4.479</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Garc&#xed;a L, Miana-Mena FJ, Moreno-Mart&#xed;nez L, de la Torre M, Lunetta C, Tarlarini C et al (2021) Inflammasome in ALS skeletal muscle: NLRP3 as a potential biomarker. Int J Mol Sci 22:2523. https://doi.org/10.3390/ijms22052523</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052523</ArticleId><ArticleId IdType="pubmed">33802349</ArticleId><ArticleId IdType="pmc">7959138</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (80) 314:130&#x2013;133. https://doi.org/10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Robberecht W (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10:253&#x2013;263</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456&#x2013;2477. https://doi.org/10.1093/brain/awr179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId><ArticleId IdType="pmc">3170532</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis. Nat Neurosci 17:17&#x2013;23. https://doi.org/10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A, Peter RS, Erhardt S, Lul&#xe9; D, Rothenbacher D, Ludolph AC et al (2017) Epidemiology of amyotrophic lateral sclerosis in Southern Germany. J Neurol 264:749&#x2013;757. https://doi.org/10.1007/s00415-017-8413-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8413-3</ArticleId><ArticleId IdType="pubmed">28220290</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Chen HJ, Shaw CE (2015) TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics 12:352&#x2013;363. https://doi.org/10.1007/s13311-015-0338-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId><ArticleId IdType="pmc">4404432</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Pei L, Yao S, Wu Y, Shang Y (2017) NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci 11:63. https://doi.org/10.3389/fncel.2017.00063</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00063</ArticleId><ArticleId IdType="pubmed">28337127</ArticleId><ArticleId IdType="pmc">5343070</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 10:661&#x2013;670. https://doi.org/10.1038/nrneurol.2014.184</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197&#x2013;206. https://doi.org/10.1126/science.1249098</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1249098</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId><ArticleId IdType="pmc">5585017</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal DR, R&#xfc;b U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K et al (2000) Sequence of A&#x3b2;-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733&#x2013;748. https://doi.org/10.1093/jnen/59.8.733</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/59.8.733</ArticleId><ArticleId IdType="pubmed">10952063</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Robberecht W, Van Den Bosch L (2017) Modelling amyotrophic lateral sclerosis: progress and possibilities. Dis Model Mech 10:537&#x2013;549. https://doi.org/10.1242/dmm.029058</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId><ArticleId IdType="pmc">5451175</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Poel M, Ulas T, Mizee MR, Hsiao C, Miedema SSM, Schuurman KG et al (2019) Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes. Nat Commun 10:1139. https://doi.org/10.1038/s41467-019-08976-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-08976-7</ArticleId><ArticleId IdType="pubmed">30867424</ArticleId><ArticleId IdType="pmc">6416318</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Schoor E, Koper MJ, Ospitalieri S, Dedeene L, Tom&#xe9; SO, Vandenberghe R et al (2020) Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS/FTLD cases. Neuropathol Appl Neurobiol 47:328&#x2013;345. https://doi.org/10.1111/nan.12668</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12668</ArticleId><ArticleId IdType="pubmed">32949047</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Walle L, Lamkanfi M (2016) Pyroptosis. Curr Biol 26:R568&#x2013;R572. https://doi.org/10.1016/j.cub.2016.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2016.02.019</ArticleId><ArticleId IdType="pubmed">27404251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Chi J, Huang D, Ding L, Zhao X, Jiang L et al (2020) &#x3b1;-synuclein promotes progression of Parkinson&#x2019;s disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome. Exp Ther Med 19:931&#x2013;938. https://doi.org/10.3892/etm.2019.8297</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.8297</ArticleId><ArticleId IdType="pubmed">32010254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. PNAS 106:18809&#x2013;18814. https://doi.org/10.1073/pnas.0908767106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId><ArticleId IdType="pmc">2762420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Leigh PN (2009) Amyotrophic lateral sclerosis. Orphanet J Rare Dis 4:3. https://doi.org/10.1186/1750-1172-4-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId><ArticleId IdType="pmc">2656493</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Zhao G (2014) Pyroptosis and neurological diseases. Neuroimmunol Neuroinflammation 1:60&#x2013;65. https://doi.org/10.4103/2347-8659.139716</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2347-8659.139716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Zhang L, Liang B, Schroeder D, Zhang Z, Cox GA et al (2016) Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders. Nat Neurosci 19:557&#x2013;559. https://doi.org/10.1038/nn.4257</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4257</ArticleId><ArticleId IdType="pubmed">26900927</ArticleId><ArticleId IdType="pmc">4811704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K et al (2020) Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer&#x2019;s disease. Sci Adv 6:eabb8680. https://doi.org/10.1126/sciadv.abb8680</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abb8680</ArticleId><ArticleId IdType="pubmed">33277246</ArticleId><ArticleId IdType="pmc">7717916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH et al (2015) TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Exp Neurol 273:24&#x2013;35. https://doi.org/10.1016/j.expneurol.2015.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou K, Shi L, Wang Y, Chen S, Zhang J (2016) Recent advances of the NLRP3 inflammasome in central nervous system disorders. J Immunol Res 2016:9238290. https://doi.org/10.1155/2016/9238290</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9238290</ArticleId><ArticleId IdType="pubmed">27652274</ArticleId><ArticleId IdType="pmc">5019917</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Cynader MS, Jia W (2015) TDP-43 inhibits NF-&#x3ba;B activity by blocking p65 nuclear translocation. PLoS ONE 10:e0142296. https://doi.org/10.1371/journal.pone.0142296</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142296</ArticleId><ArticleId IdType="pubmed">26571498</ArticleId><ArticleId IdType="pmc">4646651</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>